RepliCel Life Sciences Float d'actions
Quel est le Float d'actions de RepliCel Life Sciences?
Le Float d'actions de RepliCel Life Sciences, Inc. est 20.365M 52.85%
Quelle est la définition de Float d'actions ?
Le flottant des actions est la partie des actions d’une société qui est entre les mains d’investisseurs publics, par opposition aux actions immobilisées.
Shares float represents the portion of shares of a corporation that are in the hands of public investors as opposed to locked-in stock held by promoters, company officers, controlling-interest investors, or government. This number is sometimes seen as a better way of calculating market capitalization because it provides a more accurate reflection of what public investors consider the company to be worth. In this context, the float may refer to all the shares outstanding that can be publicly traded
The float is calculated by subtracting the locked-in shares from outstanding shares. Stocks with smaller floats tend to be more volatile than those with larger floats. In general, the large holdings of founding shareholders, corporate cross-holdings, and government holdings in partially privatized companies are excluded when calculating the size of a public float.
Float d'actions des entreprises dans Health Care secteur sur TSXV par rapport à RepliCel Life Sciences
Que fait RepliCel Life Sciences?
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01, which has completed Phase I clinical trials for the treatment of chronic tendinosis; RCS-01 that is in Phase 2 clinical trials to treat aging and sun damaged skin; and RCH-01, which is in Phase 2 clinical trials for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. RepliCel Life Sciences Inc. is headquartered in Vancouver, Canada.
Entreprises avec float d'actions similaire à RepliCel Life Sciences
- Apcotex Industries a Float d'actions de 20.294M 39.14%
- Taiga Motors a Float d'actions de 20.296M 65.06%
- Apcotex Industries a Float d'actions de 20.326M 39.21%
- Lok'nStore Plc a Float d'actions de 20.348M 67.88%
- High Liner Foods a Float d'actions de 20.351M 61.01%
- Surya Roshni a Float d'actions de 20.353M 37.41%
- RepliCel Life Sciences a Float d'actions de 20.365M 52.85%
- Immunodiagnostic Systems PLC a Float d'actions de 20.371M 70.77%
- Project Angel Parent a Float d'actions de 20.396M 25.35%
- Amesite a Float d'actions de 20.405M 92.81%
- Geyser Brands a Float d'actions de 20.407M 35.06%
- Dacian Gold a Float d'actions de 20.410M 1.68%
- Aurex a Float d'actions de 20.411M 85.26%